Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Malignant Tumor”

5,715 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,715 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Early research (Phase 1)Ended earlyNCT01705106
What this trial is testing

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Chicago 21
Not applicableStudy completedNCT04788758
What this trial is testing

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 76
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Looking for participantsNCT06003621
What this trial is testing

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Who this might be right for
Solid Tumor, Adult
Omico 96
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Testing effectiveness (Phase 2)Looking for participantsNCT05970016
What this trial is testing

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Who this might be right for
Patients with Advanced Solid Tumors
Beijing Tide Pharmaceutical Co., Ltd 56
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Early research (Phase 1)Looking for participantsNCT06211647
What this trial is testing

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ruimin Wang 20
Early research (Phase 1)Study completedNCT02223247
What this trial is testing

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Who this might be right for
Solid Malignant Tumor
Sagimet Biosciences Inc. 180
Early research (Phase 1)Study completedNCT00165802
What this trial is testing

A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors

Who this might be right for
Cancer, Malignant Tumors
Eisai Inc. 40
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Early research (Phase 1)Ended earlyNCT01378377
What this trial is testing

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Who this might be right for
Advanced Solid Tumor
EMD Serono 33
Early research (Phase 1)Looking for participantsNCT04740398
What this trial is testing

CBP-1008 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Coherent Biopharma (Suzhou) Co., Ltd. 143
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Testing effectiveness (Phase 2)Study completedNCT01554371
What this trial is testing

Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies

Who this might be right for
Malignant Solid TumourBreast Cancer Nos Metastatic RecurrentNeuropathy
University of California, San Francisco 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT07059832
What this trial is testing

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

Who this might be right for
Cancer
First Hospital of China Medical University 30
Load More Results
40